U.S. Stock News

If you are wondering whether Expeditors International of Washington at US$162.41 is offering good value right now, it helps to step back and look at what the current price might be implying. The stock has posted returns of 2.2% over the last 7 days, 8.5% over 30 days, 6.9% year to date, 49.0% over 1 year and 57.7% over 3 years, with a 5 year return of 83.4%. This naturally raises questions about how much of the story is already priced in. Recent attention on Expeditors has centered on its...

Scholar Rock recently outlined its 2026 plans around potential U.S. and European approvals and commercial launch preparations for apitegromab in spinal muscular atrophy, alongside ongoing clinical trials and leadership changes to support a move toward commercialization. An interesting angle is how Scholar Rock is extending apitegromab into younger SMA populations and facioscapulohumeral muscular dystrophy while scaling manufacturing and organizational capacity to support a broader...

Why Microvast’s New Finance Leadership Matters for Investors Microvast Holdings (MVST) has refreshed its senior finance team, naming interim finance lead Rodney Worthen as Chief Financial Officer and hiring former NextDecade executive Eric N. Garcia as Chief Accounting Officer. These appointments concentrate financial reporting, planning, and corporate development experience at the top of Microvast’s battery and energy storage business, which already reports annual revenue of US$444.5 million...

Recent financial media coverage has pushed LexinFintech Holdings (LX) into the spotlight as a penny stock candidate, with attention centering on its fundamentals and its role within consumer finance during broader market volatility. See our latest analysis for LexinFintech Holdings. Despite the recent media spotlight, LexinFintech Holdings has faced pressure, with a 90 day share price return of a 40.12% decline and a 1 year total shareholder return of a 54.17% decline, suggesting momentum has...

Spire Global (SPIR) is back in focus after the company launched nine satellites on SpaceX's Twilight mission, including its HyMS weather sensor and eight satellites supporting Myriota's global IoT connectivity network. See our latest analysis for Spire Global. That satellite launch comes on the back of a sharp swing in sentiment, with a 72.51% 30 day share price return and a 55.06% year to date share price return, even though the 1 year total shareholder return is still a 32.65% decline. If...

Earlier this month, FuelCell Energy ended the employment of its Executive Vice President, General Counsel and Corporate Secretary Joshua Dolger without cause, and appointed Amanda J. Schreiber to those roles effective January 12, 2026. Schreiber’s extensive experience guiding complex power projects, governance, and risk management at ContourGlobal brings a power-sector-focused legal and compliance perspective to FuelCell Energy’s leadership team. Next, we’ll examine how Schreiber’s...

Latest Earnings Snapshot and How It Fits the Story Regions Financial (RF) has wrapped up FY 2025 with fourth quarter revenue of US$1,806 million and EPS of US$0.59, alongside trailing 12 month revenue of US$7.1 billion and EPS of US$2.31 that frame the full year picture. Over recent quarters the company has seen revenue move from US$1,660 million in Q1 2025 to US$1,811 million in Q3 2025, and EPS range between US$0.51 and US$0.62. This gives investors a clear line of sight on how the top line...

Conference spotlight and why investors are watching LightPath Technologies (LPTH) is set to present at the 28th Annual Needham Growth Conference at The Lotte New York Palace Hotel in New York, and that upcoming appearance is drawing fresh attention from investors. See our latest analysis for LightPath Technologies. That conference appearance comes after a sharp run in the shares, with a 30 day share price return of 82.70% and a 1 year total shareholder return of 273.00%. This suggests...

If you are wondering whether AdaptHealth's share price lines up with its underlying worth, you are not alone. This article focuses squarely on what the current price might be implying about value. The stock last closed at US$10.61, with returns of 1.1% over 7 days, 1.2% over 30 days, 9.7% year to date and 0.9% over 1 year. These figures are set against much weaker 3 year and 5 year returns of 49.5% and 72.1% declines. Recent coverage has focused on AdaptHealth's position in the home...

BlackRock (BLK) has wrapped up FY 2025 with fourth quarter revenue of US$7.0b and basic EPS of US$7.26, while trailing 12 month figures show revenue of US$24.2b and EPS of US$35.83. Over recent periods, revenue has moved from US$20.4b in the trailing 12 months to Q4 2024 to US$24.2b by Q4 2025, with basic EPS shifting from US$42.45 to US$35.83 over the same comparison window. With trailing net profit margin at 22.9%, down from 31.2% a year earlier, the latest results pair solid top line...

Why Compass Therapeutics Is On Investors’ Radar Compass Therapeutics (CMPX) has drawn attention after recent share price moves, with the stock showing double digit returns over the past month and past 3 months despite reporting a net loss and no revenue. See our latest analysis for Compass Therapeutics. At a share price of $5.70, Compass Therapeutics has a 30 day share price return of 14.92% and a 90 day share price return of 33.80%. Its 1 year total shareholder return of 119.23% suggests...

Mereo BioPharma Group (NasdaqCM:MREO) has come into focus after releasing mixed Phase 3 results for setrusumab in osteogenesis imperfecta, along with a cash runway update to mid-2027 and progress on its alvelestat and vantictumab programs. See our latest analysis for Mereo BioPharma Group. The mixed Phase 3 readout and cash runway update come after a volatile stretch for the stock, with a 7 day share price return of 29.45% following a 30 day share price return decline of 66.67%, and a 1 year...

Rigel Pharmaceuticals (RIGL) has drawn fresh attention after launching a Phase 1b/2 trial combining REZLIDHIA with other therapies for acute myeloid leukemia and issuing full year 2026 revenue guidance of US$275 million to US$290 million. See our latest analysis for Rigel Pharmaceuticals. Despite the latest clinical update and 2026 revenue guidance, Rigel Pharmaceuticals’ recent share price performance has cooled, with a 7 day share price return of 8.23% and a 30 day share price return of...

Private Bancorp of America (PBAM) has wrapped up FY 2025 with fourth quarter revenue of US$29.9 million and basic EPS of US$1.75, alongside trailing twelve month revenue of US$119.2 million and EPS of US$7.09. Over recent periods, the company has seen quarterly revenue move from US$26.8 million in Q3 2024 to just over US$30.5 million in Q2 2025, with quarterly EPS ranging from about US$1.64 to US$1.83 over that span. This sets a clear earnings base for investors to work from. With a trailing...

J.B. Hunt Transport Services (JBHT) just wrapped up FY 2025 with fourth quarter revenue of US$3.1b and basic EPS of US$1.90, alongside net income of US$181.1m. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.1b in Q4 2025, while basic EPS shifted from US$1.53 to US$1.90 over the same period. Trailing twelve month EPS stands at US$6.12 on revenue of US$12.0b. With net margin at 5.0% and slightly higher than last year, the focus this season is on how efficiently...

Mountain Pacific Bancorp (MPCB) just wrapped up FY 2025 with fourth quarter revenue of about US$10.0 million and net income of US$3.1 million, set against a trailing twelve month total of US$38.7 million in revenue and US$13.1 million in net income. The company has seen revenue move from US$28.7 million to US$38.7 million on a trailing basis, while trailing earnings growth of 67.1% and a net profit margin of 33.9% frame a results season in which profitability and efficiency are front and...

If you are wondering whether SouthState Bank's share price reflects its true worth, you are not alone. This article walks through what the current market price might be implying about value. The stock last closed at US$98.43, with returns of 0.8% over the past week, 0.8% over the last month, 4.5% year to date and 1.2% over the past year, while the 3 year and 5 year returns sit at 37.1% and 40.1% respectively. Recent moves in U.S. regional bank shares have kept investor attention on balance...

Recently, Chime Financial reported slowing growth and sequential declines in purchase volume, prompting investors to reassess the fintech’s competitive position and outlook. At the same time, Chime is pushing into higher-margin products, in-house payment processing, and AI-driven features to broaden its customer base and improve unit economics. We’ll now examine how Chime’s shift to its own payment processing platform could influence the company’s investment narrative and long-term...

Kopin (KOPN) is back on investor radar after Theon International placed a US$1 million development order for the company’s DarkWAVE module, moving the micro display platform toward production readiness for international defense customers. See our latest analysis for Kopin. Theon’s order and Kopin’s January conference appearances have landed at a time when the 30 day share price return of 18.4% contrasts with a weaker 90 day share price return of 18.68%, while the 1 year total shareholder...

If you are wondering whether Fluence Energy at around US$25.50 offers good value, or if the recent excitement has pushed the price too far, this breakdown is for you. The stock has seen returns of 20.4% over 7 days, 19.7% over 30 days, 10.8% year to date, and 63.7% over 1 year. These moves have attracted investors who are considering growth potential and changes in risk. Recent news flow has focused on Fluence Energy as a key player in energy storage solutions, with ongoing attention on how...

In recent days, Figure Technology Solutions launched its On-Chain Public Equity Network (OPEN), a blockchain-based platform that enables companies to issue, trade, and settle real equity directly on the Provenance blockchain while bypassing traditional intermediaries. This move highlights Figure’s push to make tokenized real-world equity more accessible, including peer-to-peer share lending and direct transfers that aim to cut friction in conventional market infrastructure. With this...

Frontier Communications Parent (FYBR) has attracted attention after recent share moves, with the stock last closing at $38.44. Investors are weighing this price against the company’s fundamentals and its recent return profile. See our latest analysis for Frontier Communications Parent. Putting the latest move into context, Frontier’s recent 1-day, 7-day and 90-day share price returns, alongside an 8.28% 1-year total shareholder return and 34.88% 3-year total shareholder return, point to...

GH Research PLC recently reported that the U.S. Food and Drug Administration lifted the clinical hold on its GH001 investigational new drug application, allowing U.S. subject enrollment following Phase 2b data in treatment-resistant depression showing a 15.5-point placebo-adjusted MADRS score reduction by Day 8, high remission rates with infrequent dosing, brief psychoactive sessions, and no serious treatment-related adverse events. This combination of rapid symptom relief, minimal treatment...

The Mosaic Company ( NYSE:MOS ) will pay a dividend of $0.22 on the 19th of March. The dividend yield will be 3.2...